699 8th Street
Suite 600
San Francisco, CA 94103
United States
415 632 5700
https://www.irhythmtech.com
Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 1,700
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Quentin S. Blackford | Pres, CEO & Director | 671.81k | N/A | 1979 |
Mr. Douglas J. Devine | COO & Sec. | 1.14M | N/A | 1970 |
Mr. Mark J. Day Ph.D. | Chief Technology Officer | 718.76k | 1.28M | 1971 |
Mr. David A. Vort | Strategic Advisor | 896.16k | 3.89M | 1966 |
Mr. Daniel G. Wilson | Exec. VP of Corp. Strategy | 670.09k | N/A | 1982 |
Mr. Brice Bobzien CPA | Chief Financial Officer | N/A | N/A | N/A |
Dr. Mintu P. Turakhia M.D., M.S. | Chief Medical Officer & Chief Scientific Officer | N/A | N/A | N/A |
Mr. Patrick Michael Murphy J.D. | Chief Legal Officer | N/A | N/A | 1979 |
Ms. Reyna M. Fernandez | Exec. VP & Chief HR Officer | N/A | N/A | 1967 |
Mr. Mazi Kiani | Sr. VP of Quality & Regulatory | N/A | N/A | N/A |
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
iRhythm Technologies, Inc.’s ISS governance QualityScore as of 1 February 2023 is 7. The pillar scores are Audit: 9; Board: 5; Shareholder rights: 7; Compensation: 7.